ABVC Biopharma Files 8-K/A Amendment on Listing Status
Ticker: ABVC · Form: 8-K/A · Filed: May 6, 2025 · CIK: 1173313
| Field | Detail |
|---|---|
| Company | Abvc Biopharma, Inc. (ABVC) |
| Form Type | 8-K/A |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: listing-status, amendment, compliance
TL;DR
ABVC Bio filed an 8-K/A amendment regarding its listing status - check for delisting news.
AI Summary
ABVC Biopharma, Inc. filed an 8-K/A on May 6, 2025, to amend a previous filing. The amendment concerns the company's notice of delisting or failure to satisfy a continued listing rule or standard, and transfer of listing, as of April 30, 2025. The filing also includes financial statements and exhibits.
Why It Matters
This amendment provides updated information regarding ABVC Biopharma's compliance with stock exchange listing requirements, which could impact investor confidence and stock trading.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings, especially those concerning listing status, can indicate underlying financial or operational issues that pose a risk to the company and its investors.
Key Players & Entities
- ABVC BIOPHARMA, INC. (company) — Registrant
- May 6, 2025 (date) — Filing Date
- April 30, 2025 (date) — Date of Earliest Event Reported
- Nevada (jurisdiction) — State of Incorporation
- 001-40700 (identifier) — Commission File Number
- 26-0014658 (identifier) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose of this 8-K/A filing is to amend a previous report concerning the notice of delisting or failure to satisfy a continued listing rule or standard, and transfer of listing, as of April 30, 2025.
When was this amended report filed with the SEC?
This amended report was filed with the SEC on May 6, 2025.
What is the exact name of the company filing this report?
The exact name of the company filing this report is ABVC BIOPHARMA, INC.
In which state was ABVC Biopharma, Inc. incorporated?
ABVC Biopharma, Inc. was incorporated in Nevada.
What specific item information is being reported or amended in this filing?
The item information being reported or amended relates to 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing' and 'Financial Statements and Exhibits'.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on May 6, 2025 regarding ABVC BIOPHARMA, INC. (ABVC).